146 related articles for article (PubMed ID: 3707088)
1. Long-term follow-up of early dopa treatment in Parkinson's disease.
Markham CH; Diamond SG
Ann Neurol; 1986 Apr; 19(4):365-72. PubMed ID: 3707088
[TBL] [Abstract][Full Text] [Related]
2. Treatment of Parkinson's disease: levodopa as the first choice.
Katzenschlager R; Lees AJ
J Neurol; 2002 Sep; 249 Suppl 2():II19-24. PubMed ID: 12375059
[TBL] [Abstract][Full Text] [Related]
3. Early addition of selegiline to L-Dopa treatment is beneficial for patients with Parkinson disease.
Mizuno Y; Kondo T; Kuno S; Nomoto M; Yanagisawa N
Clin Neuropharmacol; 2010; 33(1):1-4. PubMed ID: 19935410
[TBL] [Abstract][Full Text] [Related]
4. Multi-center study of Parkinson mortality with early versus later dopa treatment.
Diamond SG; Markham CH; Hoehn MM; McDowell FH; Muenter MD
Ann Neurol; 1987 Jul; 22(1):8-12. PubMed ID: 3631925
[TBL] [Abstract][Full Text] [Related]
5. Dementia and treatment with L-dopa in Parkinson's disease.
Hietanen M; Teräväinen H
Mov Disord; 1988; 3(3):263-70. PubMed ID: 3193964
[TBL] [Abstract][Full Text] [Related]
6. Long-term effect of initiating pramipexole vs levodopa in early Parkinson disease.
Parkinson Study Group CALM Cohort Investigators
Arch Neurol; 2009 May; 66(5):563-70. PubMed ID: 19433655
[TBL] [Abstract][Full Text] [Related]
7. Sydney Multicenter Study of Parkinson's disease: non-L-dopa-responsive problems dominate at 15 years.
Hely MA; Morris JG; Reid WG; Trafficante R
Mov Disord; 2005 Feb; 20(2):190-9. PubMed ID: 15551331
[TBL] [Abstract][Full Text] [Related]
8. Response to L-dopa and evolution of motor fluctuations in the early phase of treatment of Parkinson's disease.
Shif M; Kempster PA
Clin Exp Neurol; 1994; 31():38-42. PubMed ID: 7586663
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and safety of piribedil in early combination with L-dopa in the treatment of Parkinson's disease: a 6-month open study.
Suwantamee J; Nidhinandana S; Srisuwananukorn S; Laptikultham S; Pisarnpong A; Chankrachang S; Bundhukul A
J Med Assoc Thai; 2004 Nov; 87(11):1293-300. PubMed ID: 15825702
[TBL] [Abstract][Full Text] [Related]
10. The impact of treatment with levodopa on Parkinson's disease.
Shaw KM; Lees AJ; Stern GM
Q J Med; 1980; 49(195):283-93. PubMed ID: 7465763
[TBL] [Abstract][Full Text] [Related]
11. Long-term Parkinson's disease--time for optimism.
Yust-Katz S; Sthneer S; Melamed E; Djaldetti R
Biomed Pharmacother; 2008; 62(4):233-5. PubMed ID: 18294809
[TBL] [Abstract][Full Text] [Related]
12. Young onset Parkinson's disease.
Quinn N; Critchley P; Marsden CD
Mov Disord; 1987; 2(2):73-91. PubMed ID: 3504266
[TBL] [Abstract][Full Text] [Related]
13. [Rasagiline in daily clinical use. Results of a treatment study of Parkinson patients with a combination treatment].
Jost WH; Klasser M; Reichmann H
Fortschr Neurol Psychiatr; 2008 Oct; 76(10):594-9. PubMed ID: 18833504
[TBL] [Abstract][Full Text] [Related]
14. Parkinson's disease: progression and mortality in the L-DOPA era.
Di Rocco A; Molinari SP; Kollmeier B; Yahr MD
Adv Neurol; 1996; 69():3-11. PubMed ID: 8615142
[No Abstract] [Full Text] [Related]
15. The addition of bromocriptine to long-term dopa therapy in Parkinson's disease.
Selby G
Clin Exp Neurol; 1989; 26():129-39. PubMed ID: 2701877
[TBL] [Abstract][Full Text] [Related]
16. Ten-year follow-up of Parkinson's disease patients randomized to initial therapy with ropinirole or levodopa.
Hauser RA; Rascol O; Korczyn AD; Jon Stoessl A; Watts RL; Poewe W; De Deyn PP; Lang AE
Mov Disord; 2007 Dec; 22(16):2409-17. PubMed ID: 17894339
[TBL] [Abstract][Full Text] [Related]
17. The effects of early selegiline therapy on long-term levodopa treatment and parkinsonian disability: an interim analysis of a Norwegian--Danish 5-year study. Norwegian-Danish Study Group.
Larsen JP; Boas J
Mov Disord; 1997 Mar; 12(2):175-82. PubMed ID: 9087975
[TBL] [Abstract][Full Text] [Related]
18. [Clozapine in the treatment of adverse psychiatric manifestations of long-term therapy with levodopa].
Svetel MV; Sternić NM; Filipović SR; Vojvodić NM; Kostić VS
Srp Arh Celok Lek; 1997; 125(7-8):203-6. PubMed ID: 9304232
[TBL] [Abstract][Full Text] [Related]
19. Pramipexole vs levodopa as initial treatment for Parkinson disease: a 4-year randomized controlled trial.
Holloway RG; Shoulson I; Fahn S; Kieburtz K; Lang A; Marek K; McDermott M; Seibyl J; Weiner W; Musch B; Kamp C; Welsh M; Shinaman A; Pahwa R; Barclay L; Hubble J; LeWitt P; Miyasaki J; Suchowersky O; Stacy M; Russell DS; Ford B; Hammerstad J; Riley D; Standaert D; Wooten F; Factor S; Jankovic J; Atassi F; Kurlan R; Panisset M; Rajput A; Rodnitzky R; Shults C; Petsinger G; Waters C; Pfeiffer R; Biglan K; Borchert L; Montgomery A; Sutherland L; Weeks C; DeAngelis M; Sime E; Wood S; Pantella C; Harrigan M; Fussell B; Dillon S; Alexander-Brown B; Rainey P; Tennis M; Rost-Ruffner E; Brown D; Evans S; Berry D; Hall J; Shirley T; Dobson J; Fontaine D; Pfeiffer B; Brocht A; Bennett S; Daigneault S; Hodgeman K; O'Connell C; Ross T; Richard K; Watts A;
Arch Neurol; 2004 Jul; 61(7):1044-53. PubMed ID: 15262734
[TBL] [Abstract][Full Text] [Related]
20. [An analysis of long-term L-dopa treatment on 122 cases of Parkinson's disease over 14 years--when should L-dopa therapy be initiated?].
Indo T; Takahashi A
Rinsho Shinkeigaku; 1986 Apr; 26(4):363-71. PubMed ID: 3731637
[No Abstract] [Full Text] [Related]
[Next] [New Search]
